Join to View Full Profile
5230 Centre AvePittsburgh, PA 15232
Phone+1 412-760-9495
Fax+1 724-527-6589
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Nalini Rao, MD is an infectious disease specialist in Pittsburgh, Pennsylvania. She is currently licensed to practice medicine in Pennsylvania, Colorado, and Ohio. She is a Clinical Professor of Medicine at University Pittsburgh.
Education & Training
UPMC Medical EducationFellowship, Infectious Disease, 1975 - 1977
Baylor College of MedicineFellowship, Infectious Disease, 1974 - 1975
George Washington UniversityResidency, Internal Medicine, 1973 - 1974
District of Columbia General HospitalResidency, Internal Medicine, 1971 - 1973
Maulana Azad Medical CollegeClass of 1970
Certifications & Licensure
OH State Medical License Current
CO State Medical License 2011 - 2025
PA State Medical License 1976 - 2016
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 64 citationsPreoperative Decolonization Effective at Reducing Staphylococcal Colonization in Total Joint Arthroplasty PatientsAntonia F. Chen, Alma E. Heyl, Peter Z. Xu, Nalini Rao, Brian A. Klatt
The Journal of Arthroplasty. 2013-09-01 - 3 citationsReply to the Letter to the editor: Staphylococcus aureus screening and decolonization in orthopaedic surgery and reduction of surgical site infections.Antonia F. Chen, Charles B. Wessel, Nalini Rao
Clinical Orthopaedics and Related Research. 2013-08-28 - 2 citationsReply to Eisen and Denholm, Dauchy et al, Fierer, and Nguyen and JonesDouglas R. Osmon, Elie F. Berbari, Anthony R. Berendt, Daniel Lew, Werner Zimmerli
Clinical Infectious Diseases. 2013-07-01
Press Mentions
A Narrative Review of the Pathophysiology of COVID‐19 Infection Among Cancer Patients: Current Evidence and Research PerspectivesJanuary 26th, 2021
'Eco Hazards Are Risk Factors for Breast Cancer'October 30th, 2015
Grant Support
- Elucidating the contribution of amyloidogenic APP processing to AD-relevant impaired synaptic protein turnoverNORTHWESTERN UNIVERSITY AT CHICAGO2023–2024
